Skip to content. | Skip to navigation

Personal tools
Sections
You are here: Home › News › Insilicos Names Heinecke to Chief Medical Advisor Post

Insilicos Names Heinecke to Chief Medical Advisor Post

Jay Heinecke, M.D. has joined Insilicos' Scientific Advisory Board with the title of Chief Medical Advisor.

Seattle, 30 April 2007 - Biomedical software firm Insilicos today announced that Jay Heinecke, M.D. has joined Insilicos' Scientific Advisory Board with the title of Chief Medical Advisor.
Dr. Heinecke is a Professor in the University of Washington Department of Medicine and a member of the Molecular Cell Biology program of the School of Medicine. He holds the Karasinski Chair in Metabolic Research and serves as Director of the Mass Spectrometry Resource for the UW Department of Medicine. Research in the Heinecke laboratory focuses on the role of oxidative reactions in the pathogenesis of atherosclerosis and other inflammatory diseases.
"Dr. Heinecke is both a practicing medical doctor and a pioneer in diagnostic proteomics," said Insilicos Chief Scientist Dr. Bryan Prazen. "Heinecke's advice and insight will be of critical importance as Insilicos moves closer to the clinic."
"Dr. Heinecke's expertise supports Insilicos' ambition to revolutionize the diagnosis of cardiovascular disease," said Insilicos President Erik Nilsson. "Insilicos' outstanding advisory board shows our connection to cutting-edge research. Heinecke's appointment reflects our growing strength in clinical applications."
Insilicos' Scientific Advisory Board comprises:

  • Ruedi Aebersold, Professor of Systems Biology, Institute of Biotechnology, Swiss Federal Institute of Technology, Zürich.
  • Norman Dovichi, Endowed Professor of Analytical Chemistry, University of Washington.
  • David Robinson Goodlett, Associate Professor, Department of Medicinal Chemistry, University of Washington.
  • Jay Heinecke, Endowed Professor of Medicine, University of Washington Medical School.
  • Nels Olson, Chief of Preservation Research and Testing, Library of Congress.


    • More information on Insilicos' Advisory Board can be found at www.insilicos.com/about.html

    Insilicos LLC is a biomarker discovery and diagnostic development company, concentrating on cardiovascular disease.

    For more information, visit the Insilicos web site www.insilicos.com or contact Insilicos at info@insilicos.com. 'Insilicos' 'PreClue," and 'Life Science Software' are trademarks of Insilicos LLC.

     

    News
    Insilicos Publishes Paper on Cloud-based Peptide Search Jan 18, 2012
    Insilicos begins prospective heart attack study Sep 13, 2011
    Insilicos Awarded Grant for Proteomics Supercomputing Aug 12, 2011
    Insilicos Announces Appointment of Jeff Howbert as Senior Scientist Dec 15, 2010
    Insilicos Wins Therapeutic Discovery Award for Cardiovascular Diagnostic Nov 01, 2010
    Insilicos Awarded Grant Applying GPU Computing to Epistasis Oct 02, 2010
    Insilicos Announces Trial of Cardiovascular Diagnostic Sep 06, 2010
    Insilicos President Erik Nilsson Speaks on Health Information Panel Aug 30, 2010
    Insilicos Awarded Grant to Develop Cloud Computing Biomarker Search System Aug 23, 2010
    Insilicos President Erik Nilsson Writes on Cloud Computing Aug 03, 2010
    Insilicos Awarded Grant to Improve Bioinformatics Software Aug 02, 2010
    Insilicos, Collaborators Publish Results of Human Cardiovascular Study Jul 12, 2010
    Insilicos Moves to New offices Dec 07, 2009
    Insilicos, Institute for Systems Biology Announce Proteomics Software Suite Update Aug 19, 2009
    Insilicos Opens New Laboratory Aug 14, 2009
    Insilicos and The Institute for Systems Biology Announce Cloud Computing System Apr 19, 2009
    BioInform Reports on Insilicos' LARS Research Feb 13, 2009
    Insilicos Awarded Grant for Advanced Statistical Methods Feb 05, 2009
    Insilicos Appoints Fraley to Senior Scientist Post Dec 28, 2008
    Insilicos Awarded Grant to Study Ensemble Learning Methods Dec 18, 2008
    Insilicos Awarded Grant for Life Science Computing May 05, 2008
    Insilicos Wins NIH Grant for Manufacturing Apr 03, 2008
    Insilicos Heart Disease Project Wins Research Funding Jan 14, 2008
    Insilicos Awarded $1 Million Grant for Biotech Services Aug 30, 2007
    Insilicos Names Heinecke to Chief Medical Advisor Post Apr 30, 2007
    Insilicos and GeneBio Sign Global Distribution Agreement Sep 22, 2006
    Insilicos Announces Breakthrough Proteomics Software Platform May 29, 2006
    Insilicos Announces 1000th Licensed User of InsilicosViewer Mar 28, 2006
    Insilicos Awarded Grant to Study Heart Disease Mar 13, 2006
    Insilicos CEO Erik Nilsson Interviewed Feb 14, 2006
    Insilicos Awarded Grant to Commercialize Proteomics Research Feb 06, 2006
    Insilicos announces support for biotech data format Sep 14, 2005
    Insilicos Announces Web Support for Biotech Tools Aug 31, 2005
    Insilicos appoints Teresa Skarr as Director of Regulatory Affairs Jul 08, 2005
    Insilicos Announces 500th Licensed User of InsilicosViewer Jun 03, 2005
    Insilicos Presents at Invest Northwest Apr 27, 2005
    Insilicos releases new version of viewer Mar 31, 2005
    Insilicos Awarded Proteomics Grant Feb 23, 2005
    Ruedi Aebersold joins Insilicos Advisory Board Dec 14, 2004
    InsilicosViewer in the News Sep 01, 2004
    Insilicos Wins NIH Grant Apr 15, 2004
    Insilicos Releases Beta Oct 13, 2003
    Insilicos Wins Grant Jun 26, 2003
    Insilicos Platform Project Announced Sep 30, 2002
    More news…